Status:
COMPLETED
Pulmonary Hypertension in Haemodialysis Patients :Frequency and Risk Factors
Lead Sponsor:
Assiut University
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18-60 years
Brief Summary
High mortality rates due to cardiovascular disease in end-stage renal disease patients been described by epidemiological and clinical studies. It accounts for approximately 50 percent of deaths in dia...
Detailed Description
Primary whose mechanisms are incompletely known, is another vascular disease entity recently described in chronic kidney disease particularly in patients undergoing haemodialysis. It corresponds to 5t...
Eligibility Criteria
Inclusion
- 80 haemodialsis patients aged from 18 to 60 years old
- 80 haemodialysis patients are on regular haemodialysis for more than one year
Exclusion
- All patients with a high probability of secondary pulmonary hypertension, those with the following history: chronic obstructive pulmonary disease, pulmonary embolism congenital heart disease, heart failure, Bilharziasis plus active HIV infection.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 2 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03310229
Start Date
December 1 2018
End Date
December 2 2019
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut uni
Asyut, Egypt, 71515